Solana Co — Director's Dealing 2020

May 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-04-30

Reporting Person: LaViscount Joyce N (CFO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-30	Class A Common Stock	A	6399	$0.43	Acquired	77258	Direct

Footnotes

F1: These shares are represented by fully vested restricted stock awards (the "RSAs").

F2: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation.